FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 67 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $897,537 | +34.5% | 202,148 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $667,088 | +53.8% | 202,148 | +32.9% | 0.01% | +25.0% |
| Q1 2023 | $433,622 | -91.8% | 152,148 | -66.4% | 0.00% | -94.7% |
| Q4 2020 | $5,302,000 | +220.4% | 452,797 | +116.9% | 0.08% | +200.0% |
| Q3 2020 | $1,655,000 | +31.7% | 208,757 | +176.3% | 0.02% | +47.1% |
| Q4 2019 | $1,257,000 | +26.0% | 75,551 | -49.7% | 0.02% | +21.4% |
| Q3 2019 | $998,000 | – | 150,265 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |